Difficult-to-treat psoriatic arthritis (PsA) refers to cases where patients continue to experience active disease despite the use of conventional and advanced therapies. These patients often present with persistent joint inflammation, enthesitis, axial involvement, or significant skin manifestations that are refractory to treatment. The condition is further complicated by comorbidities such as obesity, fibromyalgia, and depression, which can mask or amplify symptoms. Managing difficult-to-treat PsA requires a nuanced, individualized approach that considers both disease activity and patient-reported outcomes.
As part of our 12th anniversary celebration , we bring you an informative session on difficult-to-treat psoriatic arthritis, organized in collaboration with the Women Health in Rheumatology Association and Bharati Vidyapeeth. Join renowned rheumatologist Dr. Ashish Jacob Mathew on 4…
